Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
Ashwani Verma Maintained (TEVA) at Hold with Increased Target to $11 on, Sep 20th, 2023
Ashwani Verma of UBS, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $8 to $11 on, Sep 20th, 2023.
Ashwani has made no other calls on TEVA in the last 4 months.
There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Ashwani's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Thibault Boutherin of "Morgan Stanley" Initiated at Hold and Held Target at $10 on, Thursday, May 25th, 2023
This is the rating of the analyst that currently disagrees with Ashwani
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $13 on, Friday, September 8th, 2023
